Episode 27: Management of Patients with APOL1 Kidney Disease

episode

KDIGO Conversations in Nephrology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Chris Hipkins: Labour Leader on their policy costings in the wake of PREFU, Adrian Rurawhe's death 10 min · 29 Sep 2026 · The Mike Hosking Breakfast

Nobody Knows What A Coincidence Is 36 min · 29 Sep 2026 · Toni and Ryan

NEW Nancy Guthrie Note?! Teresa Giudice Breaks Her Silence on Milania + Lindsay Clancy INNOCENT?! 52 min · 29 Sep 2026 · No Filter With Zack Peter

NPR News: 09-29-2026 2PM EDT 5 min · 29 Sep 2026 · NPR News Now

2PM ET 09/29/2026 Newscast 3 min · 29 Sep 2026 · Fox News Hourly Update

Deebo & Joe - Part 1: Reaction to Bears Beating Eagles + Maurkice Pouncey Joins 1h 4m · 29 Sep 2026 · Club Shay Shay

Report any issue

Source

Recorded28 Oct 2025

Publisheranchor.fm ↗

Handlerec:11055784

Show notes

In this second installment of KDIGO’s three-part podcast series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), welcomes Barry Freedman, MD (Wake Forest University School of Medicine, United States) for a practical discussion on patient management. They examine how APOL1 risk variants influence progression, review current therapeutic approaches, and explore emerging targeted treatments designed to improve care and outcomes for affected individuals.Learn more and access resources from the KDIGO Controversies Conference on APOL1 Kidney Disease: https://kdigo.org/conferences/apol1-kidney-disease/This podcast was supported by Vertex Pharmaceuticals.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in